Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediated

Blood

Volumn 99, Issue 10, 2002, Pages 3540-3546

  Billheimer, Jeffrey T ^a   Dicker, Ira B ^a   Wynn, Richard ^a   Bradley, Jodi D ^a   Cromley, Debra A ^a   Godonis, Helen E ^a   Grimminger, Lisa C ^a   He, Bokang ^a   Kieras, Cathy J ^a   Pedicord, Donna L ^a   Spitz, Susan M ^a   Thomas, Beth E ^a   Zolotarjova, Nina I ^a   Gorko, Mary A ^a   Hollis, Gregory F ^a   Daly, Robert N ^a   Stern, Andrew M ^a   Seiffert, Dietmar ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; FIBRINOGEN RECEPTOR ANTAGONIST; L 734217; L 739758; N [(4 METHYLPHENYL)SULFONYL] 3 [[[5,6,7,8 TETRAHYDRO 4 OXO 5 [2 (4 PIPERIDINYL)ETHYL] 4H PYRAZOLO[1,5 A][1,4]DIAZEPIN 2 YL]CARBONYL]AMINO]ALANINE; ORBOFIBAN; ROXIFIBAN; SIBRAFIBAN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CASE REPORT; CHIMPANZEE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0037093079     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.10.3540     Document Type: Article

References (43)

1. The evolving story of oral platelet glycoprotein IIb/IIIa receptor inhibitors
2. Platelet glycoprotein IIb/IIIa inhibitors: Basic and clinical aspects
3. Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularization
4. Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome
5. Randomized placebocontrolled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
6. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
7. The Epistent Investigators, Randomized placebocontrolled and balloon-angioplasty-controlled trial to assess the safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockage
8. Acute profound thrombocytopenia after c7E3 (abciximab) administration
9. Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusion
10. Abciximab readministration: Results of the ReoPro readministration registry
11. Association of eptifibatide and acute profound thrombocytopenia
12. First report of an intravenous and oral glycoprotein IIb/IIIa inhibitory (RPR 109891) in patients with recent acute coronary syndromes: Results of the TIMI 15A and 15B trials
13. Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: A randomised trial
14. Oral glycoprotein IIb/IIIa inhibition by orbofiban in patients with unstable coronary syndromes (OPUSTIMI 16) trial
15. Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers
16. Monoclonal antibodies to ligand-occupied conformers of integrin alpha lb beta 3 (glycoprotein IIb/IIIa) alter receptor affinity, specificity, and function
17. Reversible conformational changes induced in glycoprotein IIb-IIIa by a potent and selective peptidometic inhibitor
18. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor
19. Stimulation of platelet glycoprotein IIb-IIIa (alpha IIIb beta 3-integrin) functional activity by a monoclonal antibody to the N-terminal region of glycoprotein IIIa
20. Unusually stable and long-lived ligand-induced conformations of integrins
21. Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIa
22. Grycoprotein IIb/IIIa antagonists: Potential induction and detection of drug-dependent antiplatelet antibodies
23. Platelet immunology
24. The serological investigation of patients with autoimmune thrombocytopenia
25. Drug-induced platelet destruction
26. Drug-induced immune thrombocytopenia
27. Idiosyncratic drug-induced haematological abnormalities
28. Drug-induced immune thrombocytopenia: An overview of pathogenesis
29. A simple method for detecting complement-fixation by autologous platelets in autoimmune thrombocytopenic purpura
30. Detection of drug-dependent, platelet-reactive antibodies by solid-phase red cell adherence assays
31. Biotin-avidin immobilization of platelet glycoprotein (BAIPG): A new capture assay for the detection of anti-platelet antibodies
32. Platelet aggregating IgG antibody to platelet surface glycoprotein associated with thrombosis and thrombocytopenia
33. Comparative study of three methods to detect free plasma antiplatelet antibodies
34. PAICA: A method for characterizing platelet-associated antibodies - Its application to the study of idiopathic thrombocytopenic purpura and to the detection of platelet-bound c7E3
35. Sera from patient with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia
36. Detection of drug-dependent platelet-reactive antibodies by antigen-capture ELISA and flow cytometry
37. A recombinant soluble form of the integrin alpha IIb beta 3 (GP IIb-IIIa) assumes an active, ligand-binding conformation and is recognized by GPIIb-IIIa-specific monoclonal, allo-, auto-, and drug-dependent platelet antibodies
38. Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action
39. Conformationally modulation of purified glycoprotein (GP) IIb-IIIa allows proteolytic generation of active fragments from either active or inactive GP IIb-IIIa
40. Biochemical and functional consequences of dissociation of the platelet membrane glycoprotein IIb-IIIa complex
41. Cytoadhesins, integrins, and platelets
42. Platelet membrane glycoproteins: Functions in cellular interaction
43. Detection of an epitope specific for the dissociated form of glycoprotein IIIa of platelet membrane glycoprotein IIb-IIIa complex and its expression on the surface of adherent platelets